Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment using TLR7 and/or TLR9 inhibitors

Methods of treatment using TLR7 and/or TLR9 inhibitors

US Patent 9347064 · Granted May 24, 2016

Estimated economic value: $10,277,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer, infectious disease, and autoimmune disease using che2025
Toll-like receptor antagonist compounds and methods of use2025
Immunogenic composition against severe acute respiratory syndrome coronavirus 2 2025
CBL inhibitors and compositions for use in adoptive cell therapy2024
Combination therapies with Cbl-b inhibitor compounds2024
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Toll-like receptor antagonist compounds and methods of use2023
Toll-like receptor antagonist compounds and methods of use2022
Methods of treating cancer, infectious disease, and autoimmune disease using CXC2021
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2021